• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995-2012 年儿童皮肤病生活质量指数(CDLQI)的临床经验和心理测量特性。

Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.

机构信息

Centre for Socioeconomic Research, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, U.K.

出版信息

Br J Dermatol. 2013 Oct;169(4):734-59. doi: 10.1111/bjd.12437.

DOI:10.1111/bjd.12437
PMID:23679682
Abstract

The Children's Dermatology Life Quality Index (CDLQI) is a widely used questionnaire to measure the quality of life of children aged from 4 to 16 years. The purpose of this review is to summarize all published data regarding the clinical experience of the CDLQI and its psychometric properties as a single reference source for potential users. A literature search was carried out to identify all articles describing the use of the CDLQI from 1995 to November 2012. One hundred and six articles were identified, with four excluded. The CDLQI has been used in 28 countries in 102 clinical studies and is available in 44 languages, including six cultural adaptations; a cartoon version is available in 10 languages. It has been used in 14 skin conditions and used in the assessment of 11 topical drugs, nine systemic drugs, 13 therapeutic interventions and two epidemiological and other studies. There is evidence of high internal consistency, test-retest reliability, responsiveness to change, and significant correlation with other subjective and objective measures. Rasch analysis has not been carried out and more information is needed concerning minimal clinically important difference; these are areas requiring further study.

摘要

儿童皮肤病生活质量指数(CDLQI)是一种广泛用于评估 4 至 16 岁儿童生活质量的问卷。本综述旨在总结所有关于 CDLQI 的临床应用经验及其心理测量特性的已发表数据,为潜在使用者提供一个单一的参考来源。对 1995 年至 2012 年 11 月间发表的所有描述 CDLQI 使用情况的文章进行了文献检索。共发现 106 篇文章,其中 4 篇被排除。CDLQI 已在 28 个国家的 102 项临床研究中使用,有 44 种语言版本,包括 6 种文化适应性版本;有 10 种语言的卡通版本。它已用于 14 种皮肤病,并用于评估 11 种局部药物、9 种系统药物、13 种治疗干预措施和 2 种流行病学和其他研究。它具有较高的内部一致性、重测信度、对变化的反应性,以及与其他主观和客观测量指标的显著相关性。尚未进行 Rasch 分析,需要更多关于最小临床重要差异的信息;这些都是需要进一步研究的领域。

相似文献

1
Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.1995-2012 年儿童皮肤病生活质量指数(CDLQI)的临床经验和心理测量特性。
Br J Dermatol. 2013 Oct;169(4):734-59. doi: 10.1111/bjd.12437.
2
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.1994 - 2007年皮肤病生活质量指数:验证数据与临床结果的全面综述
Br J Dermatol. 2008 Nov;159(5):997-1035. doi: 10.1111/j.1365-2133.2008.08832.x. Epub 2008 Sep 15.
3
Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application.婴儿特应性皮炎生活质量指数:十年来的验证和临床应用经验。
Br J Dermatol. 2013 Oct;169(4):760-8. doi: 10.1111/bjd.12563.
4
Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.比较皮肤病生活质量指数与儿童皮肤病生活质量指数在评估16 - 17岁银屑病患者生活质量中的作用。
Br J Dermatol. 2016 Jan;174(1):152-7. doi: 10.1111/bjd.14163. Epub 2015 Nov 12.
5
The Children's Dermatology Life Quality Index (CDLQI): linguistic and cultural validation in Serbian.《儿童皮肤病生活质量指数(CDLQI)》:塞尔维亚的语言和文化验证。
J Cutan Med Surg. 2013 Sep-Oct;17(5):316-20. doi: 10.2310/7750.2013.12114.
6
The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application.《皮肤病家庭影响问卷》:测评属性及临床应用的综述。
Br J Dermatol. 2013 Jul;169(1):31-46. doi: 10.1111/bjd.12232.
7
The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.家庭皮肤病生活质量指数:衡量皮肤病的继发性影响。
Br J Dermatol. 2007 Mar;156(3):528-38. doi: 10.1111/j.1365-2133.2006.07617.x.
8
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis.使用儿童皮肤病生活质量指数(CDLQI)衡量儿童皮肤病对生活质量的影响:一项荟萃分析。
Br J Dermatol. 2016 Apr;174(4):853-61. doi: 10.1111/bjd.14361. Epub 2016 Mar 6.
9
Japanese version of the Family Dermatology Life Quality Index: Translation and validation.《家庭皮肤病生活质量指数》日文版:翻译与验证
J Dermatol. 2017 Aug;44(8):914-919. doi: 10.1111/1346-8138.13831. Epub 2017 Mar 24.
10
The Children's Dermatology Life Quality Index: validation of the cartoon version.儿童皮肤病生活质量指数:卡通版的验证
Br J Dermatol. 2003 Feb;148(2):285-90. doi: 10.1046/j.1365-2133.2003.05157.x.

引用本文的文献

1
The health-related quality of life of Brazilians with epidermolysis bullosa.患有大疱性表皮松解症的巴西人的健康相关生活质量。
Orphanet J Rare Dis. 2025 Jul 4;20(1):341. doi: 10.1186/s13023-025-03753-w.
2
Psychological Morbidity in Chronic Dermatological Disorders: A Review.慢性皮肤病中的心理疾病:综述
Indian Dermatol Online J. 2025 Apr 17;16(3):381-388. doi: 10.4103/idoj.idoj_458_24. eCollection 2025 May-Jun.
3
Assessment of Quality of Life in Children with Chronic Urticaria Using the Children's Dermatology Life Quality Questionnaire Index: A Retrospective Cohort Study.
使用儿童皮肤病生活质量问卷指数评估慢性荨麻疹患儿的生活质量:一项回顾性队列研究。
Int Arch Allergy Immunol. 2025 May 19:1-10. doi: 10.1159/000546466.
4
Assessment of quality of life, treatment practices, and associated factors among children of atopic dermatitis patients at all Africa leprosy, TB and rehabilitation training center (A.L.E.R.T): a prospective observational study.在全非洲麻风、结核病与康复培训中心(A.L.E.R.T)对特应性皮炎患者子女的生活质量、治疗方法及相关因素进行评估:一项前瞻性观察研究。
BMC Pediatr. 2025 Mar 27;25(1):241. doi: 10.1186/s12887-025-05616-6.
5
Introduction.引言。
Adv Exp Med Biol. 2024;1447:1-10. doi: 10.1007/978-3-031-54513-9_1.
6
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.阿布昔替尼可快速持久改善皮肤疼痛,并改善中重度特应性皮炎成年和青少年患者的生活质量结局。
Dermatology. 2024;240(2):243-253. doi: 10.1159/000535285. Epub 2023 Dec 11.
7
Impact of Pediatric Dermatologic Conditions on Child and Parent Quality of Life.儿科皮肤病对儿童及家长生活质量的影响。
Cureus. 2023 Jul 18;15(7):e42068. doi: 10.7759/cureus.42068. eCollection 2023 Jul.
8
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.每日一次服用100毫克阿布昔替尼治疗中度至重度特应性皮炎:疗效与安全性综述及临床实践使用的专家意见
Dermatol Ther (Heidelb). 2023 Sep;13(9):1893-1907. doi: 10.1007/s13555-023-00948-6. Epub 2023 Jul 23.
9
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability.司库奇尤单抗治疗儿童银屑病:患者选择与可接受性
Patient Prefer Adherence. 2023 Feb 16;17:421-431. doi: 10.2147/PPA.S350753. eCollection 2023.
10
Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.慢性荨麻疹与心理困扰的相关性:一项多中心横断面研究。
Acta Derm Venereol. 2023 Feb 14;103:adv00865. doi: 10.2340/actadv.v102.2939.